Marché européen des prothèses orthopédiques du genou – Tendances et prévisions du secteur jusqu’en 2029

Analyse et perspectives du marché

Le genou est la plus grosse articulation du corps. Les os supérieurs et inférieurs du genou sont séparés par deux disques (ménisques). L'os supérieur de la jambe (fémur) et les os inférieurs de la jambe (tibia et péroné) sont reliés par des ligaments et des tendons. Plusieurs raisons sont présentées, qui nécessitent l'utilisation d'instruments orthopédiques pour le genou tels que des implants de genou, des orthèses et des aides, ainsi que l'utilisation de médicaments tels que des analgésiques et des anti-inflammatoires non stéroïdiens (AINS). La raison courante de la chirurgie de remplacement du genou est de soulager la douleur intense causée par l'arthrose, les déchirures des ligaments cruciaux et collatéraux et les lésions méniscales. Les personnes qui ont besoin d'une chirurgie de remplacement du genou ont généralement des difficultés à marcher, à monter les escaliers et à s'asseoir et à se lever d'une chaise. Certaines ressentent également des douleurs au genou au repos.

Définition du marché

En Europe, les maladies orthopédiques continuent d'augmenter dans le monde entier. La maladie du genou la plus courante en Europe est l'arthrose du genou. L'arthrose du genou représente près des quatre cinquièmes de la charge de l'arthrose (OA) dans le monde et augmente avec l'obésité et l'âge. Les maladies du genou, en particulier l'arthrose du genou, sont courantes et une cause majeure d'invalidité chez la population âgée. Jusqu'à présent, l'arthrose du genou s'est avérée curable, à l'exception de l'arthroplastie du genou qui est considérée comme un traitement efficace à un stade avancé de la maladie. L'arthroplastie du genou consiste à inciser et à retirer l'os endommagé du fémur du patient et de la rotule et à le remplacer par une articulation artificielle (prothèse et implants), qui sont des implants mobiles et fixes. La prothèse et les implants sont composés de métal, de céramique et de plastique. Les ligaments sont réparés en les replaçant sur l'os d'origine dans leur position anatomique, en utilisant une petite ancre pour attacher les ligaments à l'os.

Data Bridge Market Research analyse que le marché européen du genou orthopédique connaîtra un TCAC de 5,0 % au cours de la période de prévision de 2022 à 2029.

 Europe Orthopedic Knee Market Dynamics

Drivers

• Rise in incidence of knee diseases

Orthopedic diseases continue to rise throughout the globe. The typical knee disease which occurs in Europe is knee osteoarthritis. Knee osteoarthritis accounts for almost four-fifths of osteoarthritis (OA) burden worldwide and increases with obesity and age. Knee diseases, especially knee osteoarthritis, are common and a significant cause of disability among the elderly population. Knee osteoarthritis can be treated easily in Europe. In Europe, a survey conducted by e-clinical medicine states that the prevalence of knee diseases in Europe was 19.2%.

For instance,

• In March 2020, according to a report by the Oxford Academic, the incidence of knee osteoarthritis was reported to show the highest number of cases in the U.K., followed by France, Germany, Spain, and Italy, showing the fewer record cases of knee osteoarthritis

Knee osteoarthritis is a common occurrence in Switzerland. The rise in the incidence of chronic knee disorders is expected to boost the sales and supply of medication and implants for the treatment of knees in Europe. It is expected to meet the patient's requirements. The knowledge about the prevalence and incidence of orthopedic knee diseases would help find novel solutions and aid in more collaborations and partnerships with market players based in countries in Europe.

• Rise in awareness about knee treatment in Europe

Cognizance of knee disorders, understanding, and scope of the treatment is a vital step to help and guide people suffering from osteoarthritis and meniscal injuries. It helps in achieving early detection and management. Public and private institutes' awareness about the symptoms and treatment of chronic knee diseases would result in timely treatment and provide the option to access inexpensive universal health aid and increased availability of rehabilitative therapy

For instance,

• In November 2020, the European Knee Society (EKS) had collaborated with the Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Italy, for organizing two fellowships and creating awareness about the treatment of primary and revision knee and hip replacement

From the above points, we can establish that awareness about the early treatment and use of knee implants would result in collaborations of market players with health institutions for the supply and distribution of the devices. This will result in a rise in product and business line expansion.

Opportunities

• Strategic Initiatives By Market Players

The need for medications to treat knee disorders in Europe has increased due to the rise in prevalence and incidence of chronic knee disorders, advanced therapies for knee osteoarthritis and meniscal injuries, and unmet medical needs. The factors (such as rise in incidence, cases of chronic knee disorders, and availability of advanced therapies) enhance the necessity for orthopedic rehabilitation therapy, and to achieve the market demand, minor and major market players are utilizing various strategies.

The major players are also trying to devise specific strategies, such as product launches, acquisitions, approvals, expansions, and partnerships, to ensure the smooth running of the business, avoid risks, and increase the long-term growth in the sales of the market.

For instance,

• In June 2020, Zimmer Biomet received clearance from the Food and Drug Administration (FDA) for ROSA Hip System for Robotically-Assisted Direct Anterior Total Hip Arthroplasty. The clearance received had made the ROSA Hip System available for use by diagnostic centers in Europe and made it clear for post-marketing approval
• In December 2017, amplitude SURGICAL launched the ACLip, an innovation in anterior cruciate ligament (ACL) reconstruction knee surgery. The ACLip is a knee implant that provides surgeons an enhanced method to perform knee arthroscopy surgeries and is used as an outpatient procedure. The launch had increased the sales and revenue of the knee product segment, and the novel implant was distributed in orthopedic clinics in Europe

The growth of technological advancements in orthopedic knee implants

Total knee arthroplasty is a suitable treatment for severe osteoarthritis. Despite reasonable survival rates, up to 20% of real knee arthroplasty patients remain dissatisfied. Recently, promising new technologies have been developed in knee arthroplasty and could improve functional outcomes. The robotic-assisted systems allow an accurate and reproducible bone preparation due to robotic assistance, with a 3D surgical planning, based on preoperative 3D imaging or not.

For instance,

• In November 2021, Smith & Nephew launched the turnkey' robotic-assisted surgical system; an advanced system for total and partial knee arthroplasties. The turnkey robotic surgical system was designed to measure, plan, and perform a knee surgery that is personalized to the patient's anatomy

Novel technologies are expected to improve diagnosis, risk stratification, and disease monitoring of meniscal injuries and osteoarthritis. The innovative combined drug therapies are expected to improve patient outcomes in the coming years. Hence, the use of innovative treatments is expected to create lucrative opportunities for the Europe orthopedic knee market

Restraints/Challenges

• Problems Faced While Using Orthopedic Knee Medications and Implants

Orthopedic specialists observe certain risks while using the implants and consuming the medications. The knee replacement surgeries deliver complications that arise from surgery or a faulty implant. The implant becoming loose is one of the most severe complications after knee surgery, and pain is the most common one. Loosening can cause bone fractures, instability, and serious falls. Almost all serious complications require revision surgery. The risks faced are mechanical risks, knee implant loosening and physical pain.

For instance,

• The risks incurred while using the orthopedic ceramic knee implants are implant failure due to induced aseptic loosening and hypersensitivity
• The complications occurred in metal implants after surgery are loosening, instability, dislocation, misalignment, and device failure, which can result from manufacturing defects, poorly fitted implants, or problems during surgery

The risks that occur while using the knee implants and consuming the medication would decrease the usage and supply of the knee implants and bracing and supporting devices. This may lead to a decline in sales of implants and drugs. Therefore, the risks related to knee medications and implants are expected to hinder the market growth.

• Lack of skilled professionals

The lack or shortage of skilled expertise would challenge the pace of recovery and growth in one place. Often, the unemployed people in one place have skills that are in short supply elsewhere. Moreover, rapid technological advancement in this field also leads to a lack of expertise. Despite the call to increase, the number of podiatrists in Europe and several residency training programs remain unknown.

For instance,

• In England, the data by the National Center of Biotechnology Information (NCBI) state that joint arthroplasty service has substantially declined over recent weeks throughout Europe

As skill demands are too high, it has manifested as a challenge to retain and manage skill-specified professionals. Moreover, technological advancement is another aspect that leads to the increased demand for skilled professionals

The Europe orthopedic knee market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Europe orthopedic knee market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

The data by the Academic coup states that around four million people suffer from knee osteoarthritis, across Europe and has a lifetime risk of 45% for knee osteoarthritis.

Europe orthopedic knee market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on the Europe Orthopedic Knee Market

The COVID-19 has negatively affected the market. Lockdowns and isolation during pandemics complicate the diagnosis management and treatment. The lack of access to orthopaedic clinics will further affect the market. Social isolation increases stress, despair, and social support, all of which may cause a reduction in the treatment of chronic knee injuries during the pandemic.

Recent Development

• In March, DePuy Synthes had added two more orthopedic knee products in its portfolio, to the Attune knee portfolio, during the pandemic. The two products which were added are the cementless fixed bearing knee and medial stabilized knee to it’s attune knee portfolio. The addition of the new orthopedic knee products increased the product segment revenue and increased the market size in Europe region

Europe Orthopedic Knee Market Scope

The Europe orthopedic knee market is segmented on the basis of product type, indication and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Knee arthroscopy
• Ligament Repair
• Others

On the basis of product type, the market is segmented into knee arthroscopy, ligament repair and others.

Indication

• Osteoarthritis
• Cruciate And Collateral Ligament Tears
• Meniscal Injuries
• Others

On the basis of indication, the market segmented into osteoarthritis, cruciate and collateral ligament tears, meniscal injuries and others

End User

• Hospitals
• Rehabilitation Centers
• Orthopedic Centers
• Ambulatory Surgical Centers
• Others

On the basis of end user, the market is segmented into hospitals, rehabilitation centers, orthopedic centers, ambulatory surgical centers and others.

Europe Orthopedic Knee Market Regional Analysis/Insights

The Europe orthopedic knee market is analysed and market size insights and trends are provided by country, product type, indication and end user, as referenced above.

Les pays couverts par le rapport sur le marché européen de l'orthopédie du genou sont l'Allemagne, la France, le Royaume-Uni, l'Espagne, l'Italie, la Turquie, les Pays-Bas, la Belgique, la Suisse et le reste de l'Europe. L'Allemagne devrait dominer le marché en raison de l'augmentation de l'arthrose du genou, de l'augmentation des chirurgies d'arthroplastie du genou et de la présence de divers centres orthopédiques en Allemagne.

La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements dans la réglementation du marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que les nouvelles ventes, les ventes de remplacement, la démographie des pays, l'épidémiologie des maladies et les tarifs d'importation et d'exportation sont quelques-uns des principaux indicateurs utilisés pour prévoir le scénario du marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des canaux de vente sont pris en compte lors de la fourniture d'une analyse prévisionnelle des données nationales.

Analyse du paysage concurrentiel et des parts de marché du genou orthopédique en Europe

Le paysage concurrentiel du marché européen du genou orthopédique fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liées au marché européen du genou orthopédique.

Certains des principaux acteurs opérant sur le marché européen de l'orthopédie du genou sont Smith & Nephew, Össur, OTTOBOCK, DePuy Synthes (une filiale de Johnson & Johnson Private Limited), GROUP FH ORTHO, Stryker, Zimmer Biomet., B. Braun Melsungen AG, aap Implantate AG, MicroPort Orthopedics, Inc., Exactech, Inc., Medacta International, Aequos Endoprothetik GmbH, Symbios Orthopédie SA, PETER BREHM GmbH, Bayer AG, alloPlus GmbH, Bauerfeind USA Inc., amplitude SURGICAL et CERAVER entre autres.

SKU-68177